medroxyprogesterone acetate

Generic: medroxyprogesterone acetate

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name medroxyprogesterone acetate
Generic Name medroxyprogesterone acetate
Labeler amneal pharmaceuticals ny llc
Dosage Form INJECTION, SUSPENSION
Routes
INTRAMUSCULAR
Active Ingredients

medroxyprogesterone acetate 150 mg/mL

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 60219-1467
Product ID 60219-1467_b18868d1-e830-4990-a0f2-66210a783d39
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210227
Listing Expiration 2026-12-31
Marketing Start 2025-06-10

Pharmacologic Class

Classes
progesterone congeners [cs] progestin [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 602191467
Hyphenated Format 60219-1467

Supplemental Identifiers

RxCUI
1000126
UPC
0360219146716
UNII
C2QI4IOI2G

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name medroxyprogesterone acetate (source: ndc)
Generic Name medroxyprogesterone acetate (source: ndc)
Application Number ANDA210227 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 150 mg/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (60219-1467-1) / 1 mL in 1 VIAL
  • 25 VIAL in 1 CARTON (60219-1467-2) / 1 mL in 1 VIAL
source: ndc

Packages (2)

Ingredients (1)

medroxyprogesterone acetate (150 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "b18868d1-e830-4990-a0f2-66210a783d39", "openfda": {"upc": ["0360219146716"], "unii": ["C2QI4IOI2G"], "rxcui": ["1000126"], "spl_set_id": ["a80560e1-96dd-4380-b3e1-d52719ccdd4b"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (60219-1467-1)  / 1 mL in 1 VIAL", "package_ndc": "60219-1467-1", "marketing_start_date": "20250610"}, {"sample": false, "description": "25 VIAL in 1 CARTON (60219-1467-2)  / 1 mL in 1 VIAL", "package_ndc": "60219-1467-2", "marketing_start_date": "20250610"}], "brand_name": "Medroxyprogesterone Acetate", "product_id": "60219-1467_b18868d1-e830-4990-a0f2-66210a783d39", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Progesterone Congeners [CS]", "Progestin [EPC]"], "product_ndc": "60219-1467", "generic_name": "Medroxyprogesterone Acetate", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Medroxyprogesterone Acetate", "active_ingredients": [{"name": "MEDROXYPROGESTERONE ACETATE", "strength": "150 mg/mL"}], "application_number": "ANDA210227", "marketing_category": "ANDA", "marketing_start_date": "20250610", "listing_expiration_date": "20261231"}